EntryPoint Capital’s Janux Therapeutics JANX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-12,225	Closed	-$655K	–	803
2024 Q4	$655K	Buy	+12,225	New	+$655K	0.28%	34
2024 Q3	–	Sell	-1,649	Closed	-$69.1K	–	876
2024 Q2	$69.1K	Buy	+1,649	New	+$69.1K	0.1%	456